Search

everythinglearnresearchcommunity

for

Search:↓

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Oclacitinib maleate successfully treated alopecia in Andean bears.

A new treatment for hair loss shows promise with fewer side effects.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The new biodegradable nanocarriers safely and effectively deliver drugs into the skin.

Niosomes improve aminexil's effectiveness in preventing hair loss without needing propylene glycol.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Avicennia marina extract can significantly promote hair growth in androgenic alopecia patients.

Upadacitinib effectively treats severe alopecia areata and is safe.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

The serum effectively reduces hair loss and improves hair growth without side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Researchers found two enzymes in Avicennia marina that help produce maslinic acid and corosolic acid, which have medicinal benefits.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.